STOCK TITAN

Sigyn Therapeutics, Inc. to Present at the LD Micro Main Event XIX

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Positive)
Tags
conferences

Sigyn Therapeutics (OTCQB: SIGY) will present at LD Micro Main Event XIX on Tuesday, October 21, 2025 at 4:00 PM PT at the Hotel del Coronado in San Diego. CEO and inventor Jim Joyce will deliver the presentation and the company will be available for investor meetings during the three-day event running October 19–21, 2025.

The conference features ~120 companies presenting in half-hour slots and includes keynotes, company presentations, one-on-one investor meetings, and a closing reception. A virtual registration option is available for the presentation.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction 1 Alert

-4.76% News Effect

On the day this news was published, SIGY declined 4.76%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Presentation on Tuesday, October 21st at 4:00 PM PT

San Diego, California--(Newsfile Corp. - October 17, 2025) - Sigyn Therapeutics, Inc. (OTCQB: SIGY), a developer of dialysis-like therapies to address cardiovascular disease and cancer, announced today that it will be presenting at the 19th annual Main Event on Tuesday, October 21st at 4:00 PM PT at the Hotel del Coronado in San Diego, California. Jim Joyce, CEO and Inventor will be giving the presentation.

"The Main Event is a culmination of over 25 years of hard work and passion for small company investing. There is no organization on planet Earth that cares more about small companies succeeding than LD. To be able to connect with our community in one of the most beautiful settings imaginable brings me considerable joy. We look forward to welcoming all of our patrons and ensuring that they have a wonderful time," stated Chris Lahiji, Founder of LD Micro.

Event: LD Micro Main Event XIX
Date: Tuesday, October 21st
Time: 4:00 PM

Register to watch the virtual presentation here.

Summary of LD Micro Main Event XIX

The 2025 LD Micro Main Event XIX will run from October 19th to the 21st at the Hotel del Coronado in San Diego, California.

The first day will consist of registration, keynote speakers, and some gorgeous views of the Pacific. It will be followed by two full days of company presentations and one-on-one investor meetings concluded with a closing reception.

This three-day event will feature around 120 companies, presenting in half-hour increments, and attending private meetings with investors.

About Sigyn Therapeutics, Inc.

Sigyn Therapeutics is developing dialysis-like therapies to address cardiovascular disease and cancer. Sigyn CardioDialysisTM is a first-in-class blood purification technology being advanced to treat cardiovascular disease, the leading cause of global deaths. CardioDialysisTM is designed to reduce the circulating presence of inflammatory molecules that drive cardiovascular disease progression while simultaneously targeting cholesterol transporting lipoproteins that contribute to heart attacks, strokes, and other major adverse cardiovascular events (MACE). The Company’s development pipeline includes ImmunePrep(TM) to optimize the delivery of immunotherapeutic antibodies; ChemoPrep(TM) to enhance the targeted delivery of chemotherapy; and ChemoPure(TM) to reduce chemotherapy toxicity. To learn more about Sigyn Therapeutics, visit: www.SigynTherapeutics.com

About LD Micro

LD Micro is dedicated to being the definitive resource in the small-cap space. From its industry-recognized index and robust data to hosting some of the most influential events each year, LD Micro’s mission is to provide unparalleled access and insight for those seeking the next generation of great companies.

To learn more about LD Micro, visit:
http://www.ldmicro.com

To learn more about Freedom US Markets LLC, visit:
https://www.freedomcapmkts.com/

To present or register, please contact registration@ldmicro.com.

For further information on Sigyn Therapeutics, Inc.:

Sigyn Therapeutics, Inc.
Jim Joyce
619-368-2000
jj@sigyntherapeutics.com
www.sigyntherapeutics.com

FAQ

When will Sigyn Therapeutics (SIGY) present at LD Micro Main Event XIX?

Sigyn Therapeutics (SIGY) will present on Tuesday, October 21, 2025 at 4:00 PM PT.

Who will present for Sigyn Therapeutics (SIGY) at the October 21, 2025 session?

CEO and inventor Jim Joyce will deliver Sigyn Therapeutics' presentation.

Can investors watch the Sigyn Therapeutics (SIGY) presentation virtually on October 21, 2025?

Yes. The company provides a virtual registration option to watch the presentation.

What is the schedule and location for LD Micro Main Event XIX where SIGY will present?

LD Micro Main Event XIX runs October 19–21, 2025 at the Hotel del Coronado in San Diego, with company presentations and investor meetings.

How many companies will present at LD Micro Main Event XIX where SIGY is scheduled?

About 120 companies are scheduled to present during the three-day event.

How long are company presentation slots at LD Micro Main Event XIX for SIGY?

Presentations are scheduled in half-hour increments during the event.
Sigyn Therapeutics Inc

OTC:SIGY

SIGY Rankings

SIGY Latest News

SIGY Latest SEC Filings

SIGY Stock Data

6.42M
470.88k
70.67%
5.8%
Biotechnology
Healthcare
Link
United States
San Diego